Refresh

Jubilant Pharmova Ltd. - Research Center

530019 JUBLPHARMA Group (A) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21

Sales

332.40 403.70 427.54 47.46 40.29

Operating profit

-4.90 5.00 2.93 -6.94 0.16

Interest

15.40 13.50 7.29 15.91 14.68

Gross profit

43.00 25.80 112.00 -7.17 95.67

EPS (Rs)

0.02 0.09 5.44 -0.53 5.46
Half yearly  results in details
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21

Other income

63.30 34.30 116.36 15.68 110.19

Stock adjustment

-8.80 20.90 32.72 - -

Raw material

127.70 166.80 189.26 - -

Power and fuel

- - - - -

Employee expenses

100.10 93.60 84.29 26.14 23.07

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

118.30 117.40 118.34 28.26 17.06

Provisions made

- - - - -

Depreciation

26.40 23.30 20.29 3.19 3.06

Taxation

5.10 1.00 5.08 -1.91 5.66

Net profit / loss

0.30 1.50 86.63 -8.45 86.95

Extra ordinary item

-11.20 - - - -

Prior year adjustments

- - - - -

Equity capital

15.90 15.90 15.93 15.93 15.93

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

-1.47 1.24 0.69 -14.62 0.40

GPM (%)

10.87 5.89 20.59 -11.36 63.58

NPM (%)

0.08 0.34 15.93 -13.38 57.78
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com